USPTO serial 79256120
NUTRITION ADVANCING LIFE
Reviewed by CopyMark Law Group
Reg. 5969827Status 709
- Filing date
- Status date
- Registration date
- Jan 28, 2020
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NUTRITION ADVANCING LIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle P. Ciotola
Michelle P. Ciotola Cantor Colburn LLP20 Church St.22nd FloorHartford, CT 06103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; gastro-intestinal treatment preparations; medicines for human use for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; medicines for intestinal disorders; pharmaceutical products, namely pills, capsules, tablets, caplets, liquid drops, sachets and beverages for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; chemical preparations for pharmaceutical purposes for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; chemicals for pharmaceutical use for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; diagnostic preparations for medical purposes; pharmaceutical preparations, herbal supplements and veterinary preparations all for the prevention, treatment and management of immune disorders and inflammatory diseases of the gastrointestinal system | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely pharmaceutical research and new product development, research and design thereto; scientific and technological research services in the pharmaceutical, biotechnology, biochemistry and chemistry fields; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry research and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the efficacy and safety of pharmaceuticals, namely pharmaceutical product evaluation and testing and inspection of pharmaceuticals; preparation of scientific reports relating to scientific research; analytical laboratory services, namely chemical and medical laboratories; laboratory research and analysis in the pharmaceutical, biotechnology, biochemistry and chemistry fields; development of products; development of new products; advisory services relating to scientific research; scientific consultancy and information services relating to the aforementioned services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vernx Pty Ltd
- Other trademarks owned by Vernx Biotechnology Pty Ltd
- Other trademarks owned by Vernx Biotechnology Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named NUTRITION ADVANCING LIFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 14, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jan 28, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 24, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 29, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 7, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 7, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 28, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 28, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 9, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 23, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 23, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 23, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 10, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 7, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 27, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 22, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 2, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 1, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 14, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 16, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 12, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |